Drugs Made In America Acquisition II Corp. (DMIIU) Profit After Tax (2025)
Drugs Made In America Acquisition (DMIIU) posted quarterly Profit After Tax of $4.3 million for Q4 2025, up 9482.14% quarter-over-quarter from -$46158.0 in Q3 2025.
Drugs Made In America Acquisition II Corp. (DMIIU) Profit After Tax (2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIU) has reported Profit After Tax for 1 consecutive years, with $4.3 million the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.33 Mn |
| Sep 30, 2025 | -46,158.00 |